by sagarp4412@gmail.com | Aug 9, 2026 | AI
A CXO Briefing for Life Sciences Leadership Commercial organizations have entered an era where AI-driven targeting, omnichannel engagement, and next best action engines are increasingly dependent on the quality of HCP reference data. At the same time, the provider...
by sagarp4412@gmail.com | Aug 9, 2026 | Articles
A CXO Briefing for Life Sciences LeadershipAs drug launches become increasingly complex and competitive, commercial success is no longer secured by execution alone. The organizations consistently outperforming the market are those that make better commercial decisions...
by Bramarambika B | Aug 7, 2026 | Spreadsheet Modelling
Quick Overview: Pharma commercial teams rarely lack data – they lack a reliable way to make IQVIA’s prescriber and claims data and Veeva’s CRM engagement data agree with each other. Most attempts to fix this start with a dashboard or a CRM...
by Bramarambika B | Aug 7, 2026 | Spreadsheet Modelling
Quick Overview: Most pharma commercial teams don’t have to choose between IQVIA and Veeva -they run both, with Veeva CRM capturing field and engagement activity while IQVIA supplies prescriber, claims, and reference data. The problem isn’t which vendor to...
by Bramarambika B | Aug 7, 2026 | Spreadsheet Modelling
Quick Overview: Since the Veeva–Salesforce split, pharma commercial and IT leaders no longer have one obvious CRM path -they have at least two credible architectures, each with different data model assumptions, integration costs, and long-term lock-in risks. This blog...
Recent Comments